Stock Events

Stock Events

Nightingale Health Oyj 

€1.4100
12
-€0.02-1.4% 07:01 Today

Statistics

Day High
1.41
Day Low
1.41
52W High
2.41
52W Low
0.766
Volume
0
Avg. Volume
24
Mkt Cap
57.15M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

Sep 16Expected
Q4 2025
Q2 2026
-0.16
-0.15
-0.14
-0.14
Expected EPS
-0.14435238678999998
Actual EPS
-0.158475027886572

Financials

-335.73%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
5.5MRevenue
-18.47MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 7XE.MU. It's not an investment recommendation.
Nordea Bank Abp
4
NDA-FI.HE
Fortum Oyj
4
FORTUM.HE
Neste OYJ
4
NESTE.HE
Metso
3
METSO.HE

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Illumina
ILMN
Mkt Cap35.63B
Illumina provides genomic sequencing and array-based technologies which are fundamental in personalized health solutions, similar to Nightingale's health analytics.
Thermo Fisher Scientific
TMO
Mkt Cap257.71B
Thermo Fisher Scientific offers biotechnology product development including diagnostics and healthcare solutions that overlap with Nightingale's offerings.
Guardant Health
GH
Mkt Cap23.99B
Guardant Health specializes in blood-based cancer diagnostics, competing in the liquid biopsy space where Nightingale also operates.
Qiagen NV
QGEN
Mkt Cap10.37B
Qiagen is a provider of sample and assay technologies for molecular diagnostics, applied testing, and academic research, competing in the diagnostics space.
Bio-Rad Laboratories
BIO
Mkt Cap9.95B
Bio-Rad Laboratories manufactures and supplies products and systems used for gene expression which are used in similar applications as Nightingale's technologies.
Fulgent Genetics
FLGT
Mkt Cap567.37M
Fulgent Genetics offers comprehensive genetic testing, directly competing with Nightingale's approach to health diagnostics through genetic insights.
Pacific Biosciences of California
PACB
Mkt Cap809.71M
Pacific Biosciences provides advanced DNA sequencing systems that compete with Nightingale's genomic analysis technologies.
Quest Diagnostics
DGX
Mkt Cap27.79B
Quest Diagnostics provides diagnostic testing, information, and services that overlap with Nightingale's health diagnostic solutions.

About

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
Show More
CEO
Country
Finland
ISIN
FI4000490875
WKN
000A2QR4M

Listings

OTC Link
US
NHLTY
MU
DE
7XE.MU
F
DE
7XE.F
HE
FI
HEALTH.HE

0 Comments

Share your thoughts

FAQs

What is Nightingale Health Oyj stock price today?▼
The current price of 7XE.MU is €1.41 EUR — it has decreased by -1.4% in the past 24 hours. Watch Nightingale Health Oyj stock price performance more closely on the chart.
What is Nightingale Health Oyj stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boerse Muenchen exchange Nightingale Health Oyj stocks are traded under the ticker 7XE.MU.
Is Nightingale Health Oyj stock price growing?▼
7XE.MU stock has risen by +24.23% compared to the previous week, the month change is a +29.36% rise, over the last year Nightingale Health Oyj has showed a -34.57% decrease.
What is Nightingale Health Oyj market cap?▼
Today Nightingale Health Oyj has the market capitalization of 57.15M
When is the next Nightingale Health Oyj earnings date?▼
Nightingale Health Oyj is going to release the next earnings report on March 9, 2027.
What were Nightingale Health Oyj earnings last quarter?▼
7XE.MU earnings for the last quarter are -0.16 EUR per share, whereas the estimation was -0.14 EUR resulting in a -9.78% surprise. The estimated earnings for the next quarter are N/A EUR per share.
What is Nightingale Health Oyj revenue for the last year?▼
Nightingale Health Oyj revenue for the last year amounts to 5.5M EUR.
What is Nightingale Health Oyj net income for the last year?▼
7XE.MU net income for the last year is -18.47M EUR.
In which sector is Nightingale Health Oyj located?▼
Nightingale Health Oyj operates in the Other sector.
When did Nightingale Health Oyj complete a stock split?▼
Nightingale Health Oyj has not had any recent stock splits.